Associate Professor Philip Beale

Current national competitive grants*

2007

ICON 7 A randomised, two-arm, multi-centre gynaecologic cancer intergroup trial of adding bevacizumab to standard chemotherapy (carboplatin and paclitaxel) in patients with ovarian cancer
Beale P, Investigator U
Medical Research Council (UK) Research Support ($798,155 over 5 years)

* Grants administered through the University of Sydney